查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1865439

全球益生菌补充剂市场：预测至 2032 年—按成分、剂型、用途、最终用户、分销管道和地区进行分析

Probiotic Supplements Market Forecasts to 2032 - Global Analysis By Ingredient, Form, Application, End User, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的一项研究，预计 2025 年全球益生菌补充剂市场价值为 88 亿美元，到 2032 年将达到 169 亿美元。

预计在预测期内，益生菌市场将以9.7%的复合年增长率成长。益生菌补充剂是一种膳食补充剂，含有活性有益细菌和酵母，旨在透过支持肠道微生物群来提供健康益处。在持续的科学研究和针对特定健康状况（而不仅仅是一般消化功能）的产品创新推动下，随着消费者越来越意识到肠道健康与免疫系统之间的联繫，益生菌市场持续稳定成长。

提高消费者对肠道健康的认识

越来越多的科学研究和媒体报导巩固了益生菌摄取与改善消化功能之间的关联。这一认知鼓励消费者积极主动管理肠道健康，将焦点从治疗转向预防。此外，人们对肠脑轴及其对心理健康影响的认识不断提高，也使得益生菌的消费群不再局限于传统的消化支持人群，从而显着推动了不同人群的市场需求和产品普及。

高品质、经临床研究的益生菌补充剂高成本

高活性益生菌补充剂价格高是市场渗透的一大障碍。高昂的价格源自于大量的研发投入、严格的临床试验（用于检验特定菌株的健康益处）以及复杂的生产流程（以确保细菌在复杂的供应链和保质期内保持活性）。这种定价结构使得许多注重成本的消费者无法负担这些经过验证的产品，使他们在与低品质、未经证实的替代品竞争时处于劣势，并可能限制整个市场的成长，使其主要面向更富裕的消费者。

个性化益生菌的研发

微生物组检测和数据分析技术的进步为个人化益生菌配方的开发带来了变革性的机会。这种方法突破了「一刀切」的模式，能够根据个人独特的肠道微生物组组成、健康目标和遗传倾向来客製化补充剂。这种个人化客製化有望提高功效和改善消费者体验，从而创造一个高价值的细分市场。它还有助于增强品牌忠诚度和实现溢价，使个人化益生菌成为营养科学和消费者保健领域的新前沿。

各国监管环境严格且不断变化

不同地区（包括美国FDA、欧洲EFSA和其他国家机构）对健康声明的核准、标籤要求和品质标准差异显着。这些不断变化的法规可能导致产品上市延迟、合规成本增加以及配方调整的需求。此外，益生菌缺乏统一的监管定义，造成市场混乱和违规风险，对国际扩大策略和製造商的业务稳定性构成持续威胁。

新冠疫情的感染疾病：

疫情初期扰乱了全球供应链，导致益生菌市场原料短缺和物流延误。然而，疫情也成为益生菌市场强劲成长的催化剂，这主要得益于消费者对预防医学和增强免疫力日益增长的兴趣。随着越来越多的人寻求益生菌补充剂来增强自身免疫力，市场需求显着飙升。疫情期间，电子商务在保健品购买领域的普及速度加快，肠道健康也成为主流健康议题。即使在疫情结束后，这种行为模式的改变仍对市场扩张产生正面影响。

预计在预测期内，乳酸菌细分市场将占据最大的市场份额。

由于乳桿菌属拥有悠久的研究历史，在治疗常见消化系统疾病（如大肠激躁症(IBS) 和乳糖不耐受）方面已被证实有效，并且广泛应用于从胶囊到发酵食品和饮料等各种产品中，预计在预测期内，乳桿菌属将占据最大的市场份额。此外，消费者对嗜酸乳桿菌和鼠李糖乳桿菌等乳酸桿菌菌株的高度认知和信任，巩固了其市场主导地位。乳酸桿菌属的多功能性和良好的安全性预计将持续推动强烈的需求，使其成为益生菌领域消费者和生产商的基石菌属。

预计在预测期内，免疫健康领域将实现最高的复合年增长率。

预计在预测期内，免疫健康领域将实现最高成长率，这主要得益于疫情后消费者对持续免疫支持的日益重视。大量科学证据表明，健康的肠道菌丛与强大的免疫功能密切相关，这是成长要素。此外，以科学为基础的功效行销策略也引起了全球注重健康的消费者的共鸣。消费者意识的提升、临床检验以及针对性的产品开发共同构成了强大的成长动力。

占比最大的地区：

预计北美将在整个预测期内占据最大的市场份额。这一优势得益于消费者较高的健康意识、可支配收入以及完善的膳食补充剂零售和电子商务基础设施。主要市场参与者的存在以及积极寻求预防性医疗保健解决方案的消费群进一步巩固了其市场地位。此外，儘管监管标准严格，但该地区清晰的市场通路以及消费者对高端健康产品的投资意愿，确保了其持续的收入主导地位。

复合年增长率最高的地区：

预计亚太地区在预测期内将实现最高的复合年增长率。这一加速成长主要得益于不断壮大的中产阶级及其可支配收入的增加、快速的都市化以及人们对预防性医疗保健日益增长的重视。此外，人们对肠道健康益处的认识不断提高、传统发酵食品对区域饮食文化的影响，以及国内外保健品公司积极拓展新兴市场，也是关键的成长要素。这种充满活力的环境使亚太地区成为未来市场扩张的焦点。

免费客製化服务

订阅本报告的用户可从以下免费自订选项中选择一项：

  • 公司简介
    • 对最多三家其他公司进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域分类
    • 根据客户兴趣对主要国家进行市场估算、预测和复合年增长率分析（註：基于可行性检查）
  • 竞争基准化分析
    • 基于产品系列、地域覆盖和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 引言

  • 概述
  • 相关利益者
  • 分析范围
  • 分析方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 分析方法
  • 分析材料
    • 原始研究资料
    • 二手研究资讯来源
    • 先决条件

第三章 市场趋势分析

  • 介绍
  • 司机
  • 抑制因素
  • 市场机会
  • 威胁
  • 应用分析
  • 终端用户分析
  • 新兴市场
  • 新冠疫情的感染疾病

第四章 波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代产品的威胁
  • 新参与企业的威胁
  • 公司间的竞争

5. 全球益生菌补充剂市场（按成分划分）

  • 介绍
  • 乳酸菌
  • 双歧桿菌
  • 嗜热链球菌
  • 布拉氏酵母
  • 其他菌株

6. 全球益生菌补充剂市场（以剂型划分）

  • 介绍
  • 胶囊和片剂
  • 粉末
  • 液体
  • 软糖/咀嚼片

7. 全球益生菌补充剂市场（按应用划分）

  • 介绍
  • 消化器官系统健康
  • 免疫健康
  • 免疫健康
  • 口腔健康
  • 体重管理
  • 其他用途

8. 全球益生菌补充剂市场（按最终用户划分）

  • 介绍
  • 成人
  • 婴幼儿
  • 老年人

9. 全球益生菌补充剂市场（按分销管道划分）

  • 介绍
  • 大卖场/超级市场
  • 药房和药品商店
  • 专卖店
  • 线上零售/电子商务
  • 直销

第十章 全球益生菌补充剂市场（按地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 亚太其他地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章：主要趋势

  • 合约、商业伙伴关係和合资企业
  • 企业合併（M&A）
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第十二章：公司简介

  • Chr. Hansen A/S
  • Probi AB
  • Yakult Honsha Co., Ltd.
  • Nestle SA
  • Danone SA
  • International Flavors & Fragrances Inc.（IFF）
  • Lallemand Inc.
  • BioGaia AB
  • Kerry Group plc
  • Glanbia plc
  • NOW Health Group, Inc.
  • Herbalife Nutrition Ltd.
  • Amway Corp.
  • Kemin Industries, Inc.
  • Jarrow Formulas, Inc.
  • Seed Health, Inc.
  • Bio-K Plus International Inc.
  • GNC Holdings, LLC
Product Code: SMRC32211

According to Stratistics MRC, the Global Probiotic Supplements Market is accounted for $8.8 billion in 2025 and is expected to reach $16.9 billion by 2032, growing at a CAGR of 9.7% during the forecast period. Probiotic Supplements includes dietary supplements containing live beneficial bacteria and yeasts intended to confer a health benefit by supporting the gut microbiome. It is growing steadily as consumer awareness of the gut-health-immune system connection deepens, supported by ongoing scientific research and product innovation targeting specific health conditions beyond general digestion.

Market Dynamics:

Driver:

Growing consumer awareness of gut health

Increased scientific research and media coverage have solidified the link between probiotic consumption and improved digestive function. This knowledge is driving consumers to proactively manage their gut health, shifting from treatment to prevention. Furthermore, the broadening recognition of the gut-brain axis and its impact on mental well-being is expanding the consumer base beyond traditional digestive aid seekers, thereby significantly boosting market demand and product adoption across diverse demographics.

Restraint:

High cost of high-quality, clinically-studied probiotic supplements

A significant barrier to wider market penetration is the premium price of high-efficacy probiotic supplements. These costs are attributable to extensive research and development, rigorous clinical trials to validate strain-specific health claims, and advanced manufacturing processes that ensure bacterial viability through complex supply chains and shelf life. This pricing structure places these proven products out of reach for a substantial portion of cost-sensitive consumers. Consequently, it creates a competitive disadvantage against lower-quality, unsubstantiated alternatives, potentially limiting overall market growth to more affluent segments.

Opportunity:

Expansion into personalized probiotics

A transformative opportunity lies in the development of personalized probiotic formulations, driven by advancements in microbiome testing and data analytics. This approach allows for supplements tailored to an individual's unique gut flora composition, health goals, and genetic predispositions, moving beyond a one-size-fits-all model. Such customization promises enhanced efficacy and consumer outcomes, creating a high-value market segment. Moreover, it fosters stronger brand loyalty and enables companies to command premium pricing, positioning personalized probiotics as the next frontier in nutritional science and consumer healthcare.

Threat:

Stringent and evolving regulatory landscapes across different countries

Health claim approvals, labeling requirements, and quality standards vary significantly between regions like the FDA in the U.S., EFSA in Europe, and other national bodies. These evolving regulations can delay product launches, increase compliance costs, and force reformulations. Additionally, the lack of a universal regulatory definition for probiotics creates market confusion and risks of non-compliance, posing a persistent threat to international expansion strategies and operational stability for manufacturers.

Covid-19 Impact:

The pandemic initially disrupted global supply chains, causing raw material shortages and logistical delays for the probiotic market. However, it simultaneously acted as a powerful catalyst for growth, fueled by a heightened consumer focus on preventive health and immunity. Seeking to bolster their natural defenses, individuals increasingly turned to probiotic supplements, creating a significant demand surge. This period accelerated e-commerce adoption for supplement purchases and embedded gut health deeper into the mainstream wellness conversation, a behavioral shift that continues to positively influence market expansion post-pandemic.

The lactobacillus segment is expected to be the largest during the forecast period

The lactobacillus segment is expected to account for the largest market share during the forecast period attributed to its extensive research history, proven efficacy in addressing common digestive issues like IBS and lactose intolerance, and its widespread incorporation into a diverse range of products, from capsules to fermented foods and beverages. Furthermore, strong consumer familiarity and trust in lactobacillus strains, such as L. acidophilus and L. rhamnosus, solidify its market leadership. Its versatility and established safety profile ensure continued strong demand, making it the foundational genus for both consumers and manufacturers in the probiotic space.

The immune health segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the immune health segment is predicted to witness the highest growth rate driven by a sustained post-pandemic consumer prioritization of immune support. Robust scientific evidence linking a healthy gut microbiome to robust immune function is a key growth driver. Additionally, marketing efforts are increasingly focusing on this scientifically-backed benefit, resonating with a health-conscious global population. This convergence of consumer awareness, clinical validation, and targeted product development creates a powerful growth vector.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. This leadership is anchored by high consumer health awareness, strong disposable income, and a well-established retail and e-commerce infrastructure for dietary supplements. The presence of major market players and a proactive consumer base that actively seeks out preventive health solutions further consolidates its dominant position. Moreover, while regulatory standards are strict, the region's clear market channels and consumer willingness to invest in premium wellness products ensure its continued revenue dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This accelerated growth is fueled by a burgeoning middle class with increasing disposable income, rapidly expanding urbanization, and a growing cultural emphasis on preventive healthcare. Additionally, rising awareness of gut health benefits, the influence of traditional fermented foods in local diets, and the aggressive expansion of both international and domestic supplement companies into these emerging markets are key contributors. This dynamic environment makes Asia Pacific the focal point for future market expansion.

Key players in the market

Some of the key players in Probiotic Supplements Market include Chr. Hansen A/S, Probi AB, Yakult Honsha Co., Ltd., Nestle S.A., Danone S.A., International Flavors & Fragrances Inc. (IFF), Lallemand Inc., BioGaia AB, Kerry Group plc, Glanbia plc, NOW Health Group, Inc., Herbalife Nutrition Ltd., Amway Corp., Kemin Industries, Inc., Jarrow Formulas, Inc., Seed Health, Inc., Bio-K Plus International Inc., and GNC Holdings, LLC.

Key Developments:

In June 2025, with rising lifestyle diseases and growing health awareness, India is seeing a clear shift toward proactive healthcare. Aligning with the evolving consumer need, Amway India, a leading company supporting health and wellbeing, strengthened its nutrition category offering with Nutrilite Triple Protect. A scientifically formulated, plant-based supplement powered by the natural strength of Acerola Cherry, Turmeric, and Licorice. This potent formulation has nutrients that offer triple-action benefits-supporting immunity, reducing inflammation, and providing strong antioxidant protection for the gut, skin, and immune health.

In September 2024, Lallemand Health Solutions is spotlighting the benefits of its probiotics offerings for early-life nutrition (ELN) and development. The company touts that its ingredients have been shown to strengthen, promote digestion and bolster babies' natural defenses. At the same time, evidence reveals influences on the gut-brain axis and increased metabolic health.

In June 2023, Nestle Health Science and Seres Therapeutics, Inc. announced that they have signed an agreement in which Nestle Health Science will acquire the VOWST business. Nestle Health Science has been commercializing the VOWST (fecal microbiota spores, live-brpk) capsules since its launch in June 2023 in the United States. This transaction will allow Nestle Health Science full control over the further development, commercialization, and manufacturing of VOWST in the US and worldwide.

Ingredients Covered:

  • Lactobacillus
  • Bifidobacterium
  • Streptococcus Thermophilus
  • Saccharomyces Boulardii
  • Other Strains

Forms Covered:

  • Capsules & Tablets
  • Powder
  • Liquids
  • Gummies & Chewables

Applications Covered:

  • Digestive Health
  • Immune Health
  • Immune Health
  • Oral Health
  • Weight Management
  • Other Applications

End Users Covered:

  • Adults
  • Infants & Children
  • Geriatric Population

Distribution Channels Covered:

  • Hypermarkets/Supermarkets
  • Pharmacies & Drug Stores
  • Specialty Stores
  • Online Retail/E-commerce
  • Direct Sales

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Probiotic Supplements Market, By Ingredient

  • 5.1 Introduction
  • 5.2 Lactobacillus
  • 5.3 Bifidobacterium
  • 5.4 Streptococcus Thermophilus
  • 5.5 Saccharomyces Boulardii
  • 5.6 Other Strains

6 Global Probiotic Supplements Market, By Form

  • 6.1 Introduction
  • 6.2 Capsules & Tablets
  • 6.3 Powder
  • 6.4 Liquids
  • 6.5 Gummies & Chewables

7 Global Probiotic Supplements Market, By Application

  • 7.1 Introduction
  • 7.2 Digestive Health
  • 7.3 Immune Health
  • 7.4 Immune Health
  • 7.5 Oral Health
  • 7.6 Weight Management
  • 7.7 Other Applications

8 Global Probiotic Supplements Market, By End User

  • 8.1 Introduction
  • 8.2 Adults
  • 8.3 Infants & Children
  • 8.4 Geriatric Population

9 Global Probiotic Supplements Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Hypermarkets/Supermarkets
  • 9.3 Pharmacies & Drug Stores
  • 9.4 Specialty Stores
  • 9.5 Online Retail/E-commerce
  • 9.6 Direct Sales

10 Global Probiotic Supplements Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Chr. Hansen A/S
  • 12.2 Probi AB
  • 12.3 Yakult Honsha Co., Ltd.
  • 12.4 Nestle S.A.
  • 12.5 Danone S.A.
  • 12.6 International Flavors & Fragrances Inc. (IFF)
  • 12.7 Lallemand Inc.
  • 12.8 BioGaia AB
  • 12.9 Kerry Group plc
  • 12.10 Glanbia plc
  • 12.11 NOW Health Group, Inc.
  • 12.12 Herbalife Nutrition Ltd.
  • 12.13 Amway Corp.
  • 12.14 Kemin Industries, Inc.
  • 12.15 Jarrow Formulas, Inc.
  • 12.16 Seed Health, Inc.
  • 12.17 Bio-K Plus International Inc.
  • 12.18 GNC Holdings, LLC

List of Tables

  • Table 1 Global Probiotic Supplements Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Probiotic Supplements Market Outlook, By Ingredient (2024-2032) ($MN)
  • Table 3 Global Probiotic Supplements Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 4 Global Probiotic Supplements Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 5 Global Probiotic Supplements Market Outlook, By Streptococcus Thermophilus (2024-2032) ($MN)
  • Table 6 Global Probiotic Supplements Market Outlook, By Saccharomyces Boulardii (2024-2032) ($MN)
  • Table 7 Global Probiotic Supplements Market Outlook, By Other Strains (2024-2032) ($MN)
  • Table 8 Global Probiotic Supplements Market Outlook, By Form (2024-2032) ($MN)
  • Table 9 Global Probiotic Supplements Market Outlook, By Capsules & Tablets (2024-2032) ($MN)
  • Table 10 Global Probiotic Supplements Market Outlook, By Powder (2024-2032) ($MN)
  • Table 11 Global Probiotic Supplements Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 12 Global Probiotic Supplements Market Outlook, By Gummies & Chewables (2024-2032) ($MN)
  • Table 13 Global Probiotic Supplements Market Outlook, By Application (2024-2032) ($MN)
  • Table 14 Global Probiotic Supplements Market Outlook, By Digestive Health (2024-2032) ($MN)
  • Table 15 Global Probiotic Supplements Market Outlook, By Immune Health (2024-2032) ($MN)
  • Table 16 Global Probiotic Supplements Market Outlook, By Oral Health (2024-2032) ($MN)
  • Table 17 Global Probiotic Supplements Market Outlook, By Weight Management (2024-2032) ($MN)
  • Table 18 Global Probiotic Supplements Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 19 Global Probiotic Supplements Market Outlook, By End User (2024-2032) ($MN)
  • Table 20 Global Probiotic Supplements Market Outlook, By Adults (2024-2032) ($MN)
  • Table 21 Global Probiotic Supplements Market Outlook, By Infants & Children (2024-2032) ($MN)
  • Table 22 Global Probiotic Supplements Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 23 Global Probiotic Supplements Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 24 Global Probiotic Supplements Market Outlook, By Hypermarkets/Supermarkets (2024-2032) ($MN)
  • Table 25 Global Probiotic Supplements Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 26 Global Probiotic Supplements Market Outlook, By Specialty Stores (2024-2032) ($MN)
  • Table 27 Global Probiotic Supplements Market Outlook, By Online Retail/E-commerce (2024-2032) ($MN)
  • Table 28 Global Probiotic Supplements Market Outlook, By Direct Sales (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.